Soave Darlene 13D/13G Filings for Cell Source, Inc. (CLCS)

Soave Darlene 13D and 13G filings for Cell Source, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-04-20
6:05 pm
Purchase
2009-02-28 13D Cell Source, Inc.
CLCS
Soave Darlene 3,591,754
9.900%
3,591,754increase
(New Position)
Filing